Cholesterol as a modulator of cannabinoid receptor CB
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
12 02 2021
12 02 2021
Historique:
received:
12
10
2020
accepted:
20
01
2021
entrez:
13
2
2021
pubmed:
14
2
2021
medline:
15
12
2021
Statut:
epublish
Résumé
Signaling through integral membrane G protein-coupled receptors (GPCRs) is influenced by lipid composition of cell membranes. By using novel high affinity ligands of human cannabinoid receptor CB
Identifiants
pubmed: 33580091
doi: 10.1038/s41598-021-83245-6
pii: 10.1038/s41598-021-83245-6
pmc: PMC7881127
doi:
Substances chimiques
Receptor, Cannabinoid, CB2
0
Cholesterol
97C5T2UQ7J
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3706Références
Jastrzebska, B., Debinski, A., Filipek, S. & Palczewski, K. Role of membrane integrity on G protein-coupled receptors: Rhodopsin stability and function. Prog. Lipid Res. 50, 267–277. https://doi.org/10.1016/j.plipres.2011.03.002 (2011).
doi: 10.1016/j.plipres.2011.03.002
pubmed: 21435354
pmcid: 3114187
Marino, K. A., Prada-Gracia, D., Provasi, D. & Filizola, M. Impact of lipid composition and receptor conformation on the spatio-temporal organization of mu-opioid receptors in a multi-component plasma membrane model. PLoS Comput. Biol. 12, e1005240. https://doi.org/10.1371/journal.pcbi.1005240 (2016).
doi: 10.1371/journal.pcbi.1005240
pubmed: 27959924
pmcid: 5154498
Salas-Estrada, L. A., Leioatts, N., Romo, T. D. & Grossfield, A. Lipids alter rhodopsin function via ligand-like and solvent-like interactions. Biophys. J. 114, 355–367. https://doi.org/10.1016/j.bpj.2017.11.021 (2018).
doi: 10.1016/j.bpj.2017.11.021
pubmed: 29401433
pmcid: 5984976
Escriba, P. V. et al. Role of lipid polymorphism in G protein-membrane interactions: Nonlamellar-prone phospholipids and peripheral protein binding to membranes. Proc. Natl. Acad. Sci. U.S.A. 94, 11375–11380. https://doi.org/10.1073/pnas.94.21.11375 (1997).
doi: 10.1073/pnas.94.21.11375
pubmed: 9326617
pmcid: 23471
Maxfield, F. R. & van Meer, G. Cholesterol, the central lipid of mammalian cells. Curr. Opin. Cell. Biol. 22, 422–429. https://doi.org/10.1016/j.ceb.2010.05.004 (2010).
doi: 10.1016/j.ceb.2010.05.004
pubmed: 20627678
pmcid: 2910236
Chini, B. & Parenti, M. G-protein-coupled receptors, cholesterol and palmitoylation: Facts about fats. J. Mol. Endocrinol. 42, 371–379. https://doi.org/10.1677/JME-08-0114 (2009).
doi: 10.1677/JME-08-0114
pubmed: 19131499
Manna, M. et al. Mechanism of allosteric regulation of beta2-adrenergic receptor by cholesterol. Elife https://doi.org/10.7554/eLife.18432 (2016).
doi: 10.7554/eLife.18432
pubmed: 27897972
pmcid: 5182060
Guixa-Gonzalez, R. et al. Membrane cholesterol access into a G-protein-coupled receptor. Nat. Commun. 8, 14505. https://doi.org/10.1038/ncomms14505 (2017).
doi: 10.1038/ncomms14505
pubmed: 28220900
pmcid: 5321766
Hefti, F. F. Requirements for a lead compound to become a clinical candidate. BMC Neurosci. 9, S7. https://doi.org/10.1186/1471-2202-9-S3-S7 (2008).
doi: 10.1186/1471-2202-9-S3-S7
pubmed: 19091004
pmcid: 2604885
Dawaliby, R. et al. Phosphatidylethanolamine is a key regulator of membrane fluidity in eukaryotic cells. J. Biol. Chem. 291, 3658–3667. https://doi.org/10.1074/jbc.M115.706523 (2016).
doi: 10.1074/jbc.M115.706523
pubmed: 26663081
Marheineke, K., Grunewald, S., Christie, W. & Reilander, H. Lipid composition of Spodoptera frugiperda (Sf9) and Trichoplusia ni (Tn) insect cells used for baculovirus infection. FEBS Lett. 441, 49–52 (1998).
doi: 10.1016/S0014-5793(98)01523-3
Warnock, D. E. et al. Determination of plasma membrane lipid mass and composition in cultured Chinese hamster ovary cells using high gradient magnetic affinity chromatography. J. Biol. Chem. 268, 10145–10153 (1993).
doi: 10.1016/S0021-9258(18)82184-6
Oursel, D. et al. Lipid composition of membranes of Escherichia coli by liquid chromatography/tandem mass spectrometry using negative electrospray ionization. Rapid Commun. Mass Spectrom. 21, 1721–1728. https://doi.org/10.1002/rcm.3013 (2007).
doi: 10.1002/rcm.3013
pubmed: 17477452
Morein, S., Andersson, A. S., Rilfors, L. & Lindblom, G. Wild-type Escherichia coli cells regulate the membrane lipid composition in a “window” between gel and non-lamellar structures. J. Biol. Chem. 271, 6801–6809. https://doi.org/10.1074/jbc.271.12.6801 (1996).
doi: 10.1074/jbc.271.12.6801
pubmed: 8636103
Vauquelin, G. Cell membranes and how long drugs may exert beneficial pharmacological activity in vivo. Br. J. Clin. Pharmacol. 82, 673–682. https://doi.org/10.1111/bcp.12996 (2016).
doi: 10.1111/bcp.12996
pubmed: 27135195
pmcid: 5338106
Jacobson, K. A. New paradigms in GPCR drug discovery. Biochem. Pharmacol. 98, 541–555. https://doi.org/10.1016/j.bcp.2015.08.085 (2015).
doi: 10.1016/j.bcp.2015.08.085
pubmed: 26265138
pmcid: 4967540
Overington, J. P., Al-Lazikani, B. & Hopkins, A. L. How many drug targets are there?. Nat. Rev. Drug Discov. 5, 993–996. https://doi.org/10.1038/nrd2199 (2006).
doi: 10.1038/nrd2199
pubmed: 17139284
Yin, H. & Flynn, A. D. Drugging membrane protein interactions. Annu. Rev. Biomed. Eng. 18, 51–76. https://doi.org/10.1146/annurev-bioeng-092115-025322 (2016).
doi: 10.1146/annurev-bioeng-092115-025322
pubmed: 26863923
pmcid: 4968933
Talmont, F., Lebrun, C. & Zajac, J. M. Agonist binding of human mu opioid receptors expressed in the yeast Pichia pastoris: Effect of cholesterol complementation. Neurochem. Int. 132, 104588. https://doi.org/10.1016/j.neuint.2019.104588 (2020).
doi: 10.1016/j.neuint.2019.104588
pubmed: 31704091
Veatch, S. L., Soubias, O., Keller, S. L. & Gawrisch, K. Critical fluctuations in domain-forming lipid mixtures. Proc. Natl. Acad. Sci. U.S.A. 104, 17650–17655. https://doi.org/10.1073/pnas.0703513104 (2007).
doi: 10.1073/pnas.0703513104
pubmed: 17962417
pmcid: 2077022
Chen, Z. & Rand, R. P. The influence of cholesterol on phospholipid membrane curvature and bending elasticity. Biophys. J. 73, 267–276. https://doi.org/10.1016/S0006-3495(97)78067-6 (1997).
doi: 10.1016/S0006-3495(97)78067-6
pubmed: 9199791
pmcid: 1180928
Pan, J., Tristram-Nagle, S. & Nagle, J. F. Effect of cholesterol on structural and mechanical properties of membranes depends on lipid chain saturation. Phys. Rev. E Stat. Nonlin. Soft Matter. Phys. 80, 021931. https://doi.org/10.1103/PhysRevE.80.021931 (2009).
doi: 10.1103/PhysRevE.80.021931
pubmed: 19792175
pmcid: 2756665
Rouviere, E., Arnarez, C., Yang, L. & Lyman, E. Identification of two new cholesterol interaction sites on the A2A adenosine receptor. Biophys. J. 113, 2415–2424. https://doi.org/10.1016/j.bpj.2017.09.027 (2017).
doi: 10.1016/j.bpj.2017.09.027
pubmed: 29211995
pmcid: 5738547
Gimpl, G. Interaction of G protein coupled receptors and cholesterol. Chem. Phys. Lipids 199, 61–73. https://doi.org/10.1016/j.chemphyslip.2016.04.006 (2016).
doi: 10.1016/j.chemphyslip.2016.04.006
pubmed: 27108066
Sengupta, D., Prasanna, X., Mohole, M. & Chattopadhyay, A. Exploring GPCR-lipid interactions by molecular dynamics simulations: Excitements, challenges, and the way forward. J. Phys. Chem. B 122, 5727–5737. https://doi.org/10.1021/acs.jpcb.8b01657 (2018).
doi: 10.1021/acs.jpcb.8b01657
pubmed: 29685028
Legler, D. F. et al. Modulation of chemokine receptor function by cholesterol: New prospects for pharmacological intervention. Mol. Pharmacol. 91, 331–338. https://doi.org/10.1124/mol.116.107151 (2017).
doi: 10.1124/mol.116.107151
pubmed: 28082305
Bari, M., Paradisi, A., Pasquariello, N. & Maccarrone, M. Cholesterol-dependent modulation of type 1 cannabinoid receptors in nerve cells. J. Neurosci. Res. 81, 275–283. https://doi.org/10.1002/jnr.20546 (2005).
doi: 10.1002/jnr.20546
pubmed: 15920744
Oddi, S. et al. Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptor. J Neurochem. 116, 858–865. https://doi.org/10.1111/j.1471-4159.2010.07041.x (2011).
doi: 10.1111/j.1471-4159.2010.07041.x
pubmed: 21214565
Bari, M. et al. Effect of lipid rafts on Cb2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells. J. Immunol. 177, 4971–4980 (2006).
doi: 10.4049/jimmunol.177.8.4971
Turcotte, C., Blanchet, M. R., Laviolette, M. & Flamand, N. The CB2 receptor and its role as a regulator of inflammation. Cell. Mol. Life Sci. 73, 4449–4470. https://doi.org/10.1007/s00018-016-2300-4 (2016).
doi: 10.1007/s00018-016-2300-4
pubmed: 27402121
pmcid: 5075023
Li, X. et al. Crystal structure of the human cannabinoid receptor CB2. Cell 176, 459–467. https://doi.org/10.1016/j.cell.2018.12.011 (2019).
doi: 10.1016/j.cell.2018.12.011
pubmed: 30639103
pmcid: 6713262
Yao, B. B. et al. Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging. J. Pharmacol. Exp. Ther. 328, 141–151. https://doi.org/10.1124/jpet.108.145011 (2009).
doi: 10.1124/jpet.108.145011
pubmed: 18931146
Yeliseev, A. A. Methods for recombinant expression and functional characterization of human cannabinoid receptor Cb2. Comput. Struct. Biotechnol. J. 2, 2. https://doi.org/10.5936/csbj.201303011 (2013).
doi: 10.5936/csbj.201303011
Yeliseev, A. A., Wong, K. K., Soubias, O. & Gawrisch, K. Expression of human peripheral cannabinoid receptor for structural studies. Protein Sci. 14, 2638–2653. https://doi.org/10.1110/ps.051550305 (2005).
doi: 10.1110/ps.051550305
pubmed: 16195551
pmcid: 2253291
Parathath, S. et al. Changes in plasma membrane properties and phosphatidylcholine subspecies of insect Sf9 cells due to expression of scavenger receptor class B, type I, and CD36. J. Biol. Chem. 279, 41310–41318. https://doi.org/10.1074/jbc.M404952200 (2004).
doi: 10.1074/jbc.M404952200
pubmed: 15280390
Gimpl, G., Klein, U., Reilander, H. & Fahrenholz, F. Expression of the human oxytocin receptor in baculovirus-infected insect cells: High-affinity binding is induced by a cholesterol-cyclodextrin complex. Biochemistry 34, 13794–13801. https://doi.org/10.1021/bi00042a010 (1995).
doi: 10.1021/bi00042a010
pubmed: 7577972
Huang, Z. & London, E. Cholesterol lipids and cholesterol-containing lipid rafts in bacteria. Chem. Phys. Lipids 199, 11–16. https://doi.org/10.1016/j.chemphyslip.2016.03.002 (2016).
doi: 10.1016/j.chemphyslip.2016.03.002
pubmed: 26964703
pmcid: 4972651
Liu, S. L. et al. Orthogonal lipid sensors identify transbilayer asymmetry of plasma membrane cholesterol. Nat. Chem. Biol. 13, 268–274. https://doi.org/10.1038/nchembio.2268 (2017).
doi: 10.1038/nchembio.2268
pubmed: 28024150
Mahammad, S. & Parmryd, I. Cholesterol depletion using methyl-beta-cyclodextrin. Methods Mol. Biol. 1232, 91–102. https://doi.org/10.1007/978-1-4939-1752-5_8 (2015).
doi: 10.1007/978-1-4939-1752-5_8
pubmed: 25331130
Zidovetzki, R. & Levitan, I. Use of cyclodextrins to manipulate plasma membrane cholesterol content: Evidence, misconceptions and control strategies. Biochim. Biophys. Acta 1768, 1311–1324. https://doi.org/10.1016/j.bbamem.2007.03.026 (2007).
doi: 10.1016/j.bbamem.2007.03.026
pubmed: 17493580
pmcid: 1948080
Yeliseev, A., Zoubak, L. & Schmidt, T. G. M. Application of Strep-Tactin XT for affinity purification of Twin-Strep-tagged CB2, a G protein-coupled cannabinoid receptor. Protein Expr. Purif. 131, 109–118. https://doi.org/10.1016/j.pep.2016.11.006 (2017).
doi: 10.1016/j.pep.2016.11.006
pubmed: 27867058
Yeliseev, A. et al. Thermostability of a recombinant G protein-coupled receptor expressed at high level in mammalian cell culture. Sci. Rep. 10, 16805. https://doi.org/10.1038/s41598-020-73813-7 (2020).
doi: 10.1038/s41598-020-73813-7
pubmed: 33033368
pmcid: 7546613
Vukoti, K., Kimura, T., Macke, L., Gawrisch, K. & Yeliseev, A. Stabilization of functional recombinant cannabinoid receptor CB2 in detergent micelles and lipid bilayers. PLoS ONE 7, e46290. https://doi.org/10.1371/journal.pone.0046290 (2012).
doi: 10.1371/journal.pone.0046290
pubmed: 23056277
pmcid: 3463599
Xing, C. et al. Cryo-EM structure of the human cannabinoid receptor CB2-Gi signaling complex. Cell https://doi.org/10.1016/j.cell.2020.01.007 (2020).
doi: 10.1016/j.cell.2020.01.007
pubmed: 32259487
pmcid: 8247115
Huang, W. et al. Structural insights into micro-opioid receptor activation. Nature 524, 315–321. https://doi.org/10.1038/nature14886 (2015).
doi: 10.1038/nature14886
pubmed: 26245379
pmcid: 4639397
Salari, R., Joseph, T., Lohia, R., Henin, J. & Brannigan, G. A streamlined, general approach for computing ligand binding free energies and its application to GPCR-bound cholesterol. J. Chem. Theory Comput. 14, 6560–6573. https://doi.org/10.1021/acs.jctc.8b00447 (2018).
doi: 10.1021/acs.jctc.8b00447
pubmed: 30358394
pmcid: 6467757
Kimura, T. et al. Recombinant cannabinoid type 2 receptor in liposome model activates g protein in response to anionic lipid constituents. J. Biol. Chem. 287, 4076–4087. https://doi.org/10.1074/jbc.M111.268425 (2012).
doi: 10.1074/jbc.M111.268425
pubmed: 22134924
Mouritsen, O. G. & Zuckermann, M. J. What’s so special about cholesterol?. Lipids 39, 1101–1113. https://doi.org/10.1007/s11745-004-1336-x (2004).
doi: 10.1007/s11745-004-1336-x
pubmed: 15726825
Niu, S. L., Mitchell, D. C. & Litman, B. J. Manipulation of cholesterol levels in rod disk membranes by methyl-beta-cyclodextrin: Effects on receptor activation. J. Biol. Chem. 277, 20139–20145. https://doi.org/10.1074/jbc.M200594200 (2002).
doi: 10.1074/jbc.M200594200
pubmed: 11889130
Cantor, R. S. The lateral pressure profile in membranes: A physical mechanism of general anesthesia. Biochemistry 36, 2339–2344. https://doi.org/10.1021/bi9627323 (1997).
doi: 10.1021/bi9627323
pubmed: 9054538
Andersen, O. S. & Koeppe, R. E. Bilayer thickness and membrane protein function: An energetic perspective. Annu. Rev. Biophys. Biomol. Struct. 36, 107–130. https://doi.org/10.1146/annurev.biophys.36.040306.132643 (2007).
doi: 10.1146/annurev.biophys.36.040306.132643
pubmed: 17263662
Yeagle, P. L. Modulation of membrane function by cholesterol. Biochimie 73, 1303–1310. https://doi.org/10.1016/0300-9084(91)90093-g (1991).
doi: 10.1016/0300-9084(91)90093-g
pubmed: 1664240
Pucadyil, T. J. & Chattopadhyay, A. Role of cholesterol in the function and organization of G-protein coupled receptors. Prog. Lipid Res. 45, 295–333. https://doi.org/10.1016/j.plipres.2006.02.002 (2006).
doi: 10.1016/j.plipres.2006.02.002
pubmed: 16616960
Sohlenkamp, C. & Geiger, O. Bacterial membrane lipids: Diversity in structures and pathways. FEMS Microbiol. Rev. 40, 133–159. https://doi.org/10.1093/femsre/fuv008 (2016).
doi: 10.1093/femsre/fuv008
pubmed: 25862689
Hua, T. et al. Crystal structure of the human cannabinoid receptor CB1. Cell 167, 750–762. https://doi.org/10.1016/j.cell.2016.10.004 (2016).
doi: 10.1016/j.cell.2016.10.004
pubmed: 27768894
pmcid: 5322940
Krishna Kumar, K. et al. Structure of a signaling cannabinoid receptor 1-G protein complex. Cell 176, 448–458. https://doi.org/10.1016/j.cell.2018.11.040 (2019).
doi: 10.1016/j.cell.2018.11.040
pubmed: 30639101
Reggio, P. H. Endocannabinoid binding to the cannabinoid receptors: What is known and what remains unknown. Curr. Med. Chem. 17, 1468–1486. https://doi.org/10.2174/092986710790980005 (2010).
doi: 10.2174/092986710790980005
pubmed: 20166921
pmcid: 4120766
Ehrhart, J. et al. Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation. J. Neuroinflam. 2, 29. https://doi.org/10.1186/1742-2094-2-29 (2005).
doi: 10.1186/1742-2094-2-29
Kishimoto, S. et al. Endogenous cannabinoid receptor ligand induces the migration of human natural killer cells. J. Biochem. 137, 217–223. https://doi.org/10.1093/jb/mvi021 (2005).
doi: 10.1093/jb/mvi021
pubmed: 15749836
Rudd-Schmidt, J. A. et al. Lipid order and charge protect killer T cells from accidental death. Nat. Commun. 10, 5396. https://doi.org/10.1038/s41467-019-13385-x (2019).
doi: 10.1038/s41467-019-13385-x
pubmed: 31776337
pmcid: 6881447
Yeliseev, A. A. & Vukoti, K. in Production of membrane proteins (ed A.S. Robinson) 219–248 (Wiley-VCH, 2011).
Horti, A. G. et al. Synthesis and biodistribution of [11C]A-836339, a new potential radioligand for PET imaging of cannabinoid type 2 receptors (CB2). Bioorg. Med. Chem. 18, 5202–5207. https://doi.org/10.1016/j.bmc.2010.05.058 (2010).
doi: 10.1016/j.bmc.2010.05.058
pubmed: 20554448
pmcid: 2903661
Yeliseev, A. Expression and preparation of a G-protein-coupled cannabinoid receptor CB2 for NMR structural studies. Curr. Protoc. Protein Sci. 96, e83. https://doi.org/10.1002/cpps.83 (2019).
doi: 10.1002/cpps.83
pubmed: 30624864
pmcid: 6579622
Cinar, R. et al. Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosis. JCI Insight https://doi.org/10.1172/jci.insight.87336 (2016).
doi: 10.1172/jci.insight.87336
pubmed: 27525312
pmcid: 4979564
Iyer, M. R. et al. Structural basis of species-dependent differential affinity of 6-alkoxy-5-aryl-3-pyridinecarboxamide cannabinoid-1 receptor antagonists. Mol. Pharmacol. 88, 238–244 (2015).
doi: 10.1124/mol.115.098541
Beckner, R. L., Zoubak, L., Hines, K. G., Gawrisch, K. & Yeliseev, A. A. Probing thermostability of detergent-solubilized CB2 receptor by parallel G protein-activation and ligand-binding assays. J. Biol. Chem. 295, 181–190. https://doi.org/10.1074/jbc.RA119.010696 (2020).
doi: 10.1074/jbc.RA119.010696
pubmed: 31776188
Huang, J. & MacKerell, A. D. Jr. CHARMM36 all-atom additive protein force field: Validation based on comparison to NMR data. J. Comput. Chem. 34, 2135–2145. https://doi.org/10.1002/jcc.23354 (2013).
doi: 10.1002/jcc.23354
pubmed: 23832629
pmcid: 3800559
68M. J. Frisch, G. W. T., H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, G. A. Petersson, H. Nakatsuji, X. Li, M. Caricato, A. Marenich, J. Bloino, B. G. Janesko, R. Gomperts, B. Mennucci, H. P. Hratchian, J. V. Ortiz, A. F. Izmaylov, J. L. Sonnenberg, D. Williams-Young, F. Ding, F. Lipparini, F. Egidi, J. Goings, B. Peng, A. Petrone, T. Henderson, D. Ranasinghe, V. G. Zakrzewski, J. Gao, N. Rega, G. Zheng, W. Liang, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, K. Throssell, J. A. Montgomery, Jr., J. E. Peralta, F. Ogliaro, M. Bearpark, J. J. Heyd, E. Brothers, K. N. Kudin, V. N. Staroverov, T. Keith, R. Kobayashi, J. Normand, K. Raghavachari, A. Rendell, J. C. Burant, S. S. Iyengar, J. Tomasi, M. Cossi, J. M. Millam, M. Klene, C. Adamo, R. Cammi, J. W. Ochterski, R. L. Martin, K. Morokuma, O. Farkas, J. B. Foresman, and D. J. Fox. Gaussian 09, Revision A02. Gaussian, Inc., (2016).
Vanommeslaeghe, K. et al. CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J. Comput. Chem. 31, 671–690. https://doi.org/10.1002/jcc.21367 (2010).
doi: 10.1002/jcc.21367
pubmed: 19575467
pmcid: 2888302
Lomize, M. A., Pogozheva, I. D., Joo, H., Mosberg, H. I. & Lomize, A. L. OPM database and PPM web server: Resources for positioning of proteins in membranes. Nucleic Acids Res. 40, D370-376. https://doi.org/10.1093/nar/gkr703 (2012).
doi: 10.1093/nar/gkr703
pubmed: 21890895
Lee, J. et al. CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM simulations using the CHARMM36 additive force field. J. Chem. Theory Comput. 12, 405–413. https://doi.org/10.1021/acs.jctc.5b00935 (2016).
doi: 10.1021/acs.jctc.5b00935
pubmed: 26631602